KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $934.4 million.

  • Resmed's Total Non-Current Liabilities fell 984.09% to $934.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $934.4 million, marking a year-over-year decrease of 984.09%. This contributed to the annual value of $1.2 billion for FY2025, which is 817.31% up from last year.
  • Latest data reveals that Resmed reported Total Non-Current Liabilities of $934.4 million as of Q4 2025, which was down 984.09% from $931.6 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Total Non-Current Liabilities peaked at $2.2 billion during Q4 2022, and registered a low of $930.7 million during Q2 2021.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $1.1 billion (2021), whereas its average is $1.3 billion.
  • Per our database at Business Quant, Resmed's Total Non-Current Liabilities plummeted by 4126.91% in 2021 and then surged by 12785.34% in 2022.
  • Over the past 5 years, Resmed's Total Non-Current Liabilities (Quarter) stood at $967.8 million in 2021, then surged by 127.85% to $2.2 billion in 2022, then decreased by 24.76% to $1.7 billion in 2023, then plummeted by 37.54% to $1.0 billion in 2024, then dropped by 9.84% to $934.4 million in 2025.
  • Its Total Non-Current Liabilities stands at $934.4 million for Q4 2025, versus $931.6 million for Q3 2025 and $1.2 billion for Q2 2025.